- Home
- SNY vs RMBS Comparison
SNY vs RMBS Comparison
Compare SNY & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- RMBS
- Stock Information
- Founded
- SNY 1994
- RMBS 1990
- Country
- SNY France
- RMBS United States
- Employees
- SNY N/A
- RMBS N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- RMBS Semiconductors
- Sector
- SNY Health Care
- RMBS Technology
- Exchange
- SNY Nasdaq
- RMBS Nasdaq
- Market Cap
- SNY 113.4B
- RMBS 8.0B
- IPO Year
- SNY N/A
- RMBS 1997
- Fundamental
- Price
- SNY $47.59
- RMBS $104.14
- Analyst Decision
- SNY Buy
- RMBS Strong Buy
- Analyst Count
- SNY 4
- RMBS 6
- Target Price
- SNY $61.50
- RMBS $97.83
- AVG Volume (30 Days)
- SNY 2.7M
- RMBS 1.9M
- Earning Date
- SNY 10-24-2025
- RMBS 10-27-2025
- Dividend Yield
- SNY 3.40%
- RMBS N/A
- EPS Growth
- SNY 118.56
- RMBS 0.94
- EPS
- SNY 8.65
- RMBS 2.11
- Revenue
- SNY $53,714,621,258.00
- RMBS $645,488,000.00
- Revenue This Year
- SNY $1.53
- RMBS $27.27
- Revenue Next Year
- SNY $7.06
- RMBS $13.32
- P/E Ratio
- SNY $5.43
- RMBS $46.18
- Revenue Growth
- SNY 15.65
- RMBS 35.17
- 52 Week Low
- SNY $44.73
- RMBS $38.01
- 52 Week High
- SNY $60.12
- RMBS $100.73
- Technical
- Relative Strength Index (RSI)
- SNY 47.18
- RMBS 78.89
- Support Level
- SNY $46.50
- RMBS $72.45
- Resistance Level
- SNY $47.69
- RMBS $100.73
- Average True Range (ATR)
- SNY 0.69
- RMBS 5.06
- MACD
- SNY -0.10
- RMBS 2.72
- Stochastic Oscillator
- SNY 47.94
- RMBS 99.18
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About RMBS Rambus Inc.
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.